A phase I clinical trial utilizing autologous tumor-infiltrating lymphocytes in patients with primary hepatocellular carcinoma

This report describes an ongoing Phase I clinical trial testing the safety of adoptive cell therapy (ACT) using autologous tumor-infiltrating lymphocytes (TIL) in patients with primary hepatocellular carcinoma (HCC). Fifteen HCC patients were treated with their activated and expanded TILs following...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Shan-Shan, Tang, Yan, Zhang, Yao-Jun, Weng, De-Sheng, Zhou, Zhong-Guo, Pan, Ke, Pan, Qiu-Zhong, Wang, Qi-Jing, Liu, Qing, He, Jia, Zhao, Jing-Jing, Li, Jiang, Chen, Min-Shan, Chang, Alfred E., Li, Qiao, Xia, Jian-Chuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747409/
https://www.ncbi.nlm.nih.gov/pubmed/26515587

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747409/
https://www.ncbi.nlm.nih.gov/pubmed/26515587

Ejemplares similares